Rapid Fire: The Evolution of Cellular Therapy

Rapid Fire Moderator(s)

• 

  Christopher Beaver, PhD (he/him/his)

  Head Cell Therapy Clinical Immunogenicity
  Takeda Pharmaceuticals
  Cambridge, Massachusetts, United States

Presentations:

• 2:30 PM – 2:45 PM ET

  Clinical Relevance of Immunogenicity for Cell Therapies
  

  Rapid Fire Speaker: Weifeng Xu, PhD – Merck & Co., Inc.
• 2:45 PM – 3:00 PM ET

  Extending Blood Stability for Clinical ELISpot
  

  Rapid Fire Speaker: Xinyuan Li, PhD – Janssen R&D
• 3:00 PM – 3:15 PM ET

  A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
  

  Rapid Fire Speaker: Jane E. Craig, PhD (she/her/hers) – Labcorp Drug Development
• 3:15 PM – 3:30 PM ET

  An Evolution of CARs – Autologous vs Allogeneic Strategies
  

  Rapid Fire Speaker: Keith Rennier, PhD – Labcorp Drug Development